7-(3-Bromo-4-fluoro-phenyl)-5-methyl-1,1-dioxo-2,3,4,7-tetrahydro-1H-1lambda*6*-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester

ID: ALA3138594

PubChem CID: 11247419

Max Phase: Preclinical

Molecular Formula: C17H17BrFNO4S

Molecular Weight: 430.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(C)NC2=C(C1c1ccc(F)c(Br)c1)S(=O)(=O)CC2

Standard InChI:  InChI=1S/C17H17BrFNO4S/c1-3-24-17(21)14-9(2)20-13-6-7-25(22,23)16(13)15(14)10-4-5-12(19)11(18)8-10/h4-5,8,15,20H,3,6-7H2,1-2H3

Standard InChI Key:  FQUNCHVVRAKHSO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    2.6559    0.4800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4202    0.7786    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.2252    0.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9231    0.8546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6986   -0.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2685   -0.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0094   -0.7924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800    1.6781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4920    0.7880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4977   -0.5436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9414    0.1428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    2.0521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2437    0.8217    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8113    1.3347    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0955    2.8839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7934    3.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5697    2.1270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4489    1.6115    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5266    2.9505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3627    3.2584    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2018    0.3388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5789   -0.8715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7503    4.1568    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9346    0.7133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6242    0.2643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4  1  1  0
  5  1  2  0
  6  7  1  0
  7  5  1  0
  8  4  1  0
  9  3  1  0
 10  5  1  0
 11  2  1  0
 12  8  2  0
 13  2  2  0
 14  2  2  0
 15 12  1  0
 16 19  1  0
 17  8  1  0
 18  9  2  0
 19 17  2  0
 20 15  1  0
 21  9  1  0
 22  6  1  0
 23 16  1  0
 24 21  1  0
 25 24  1  0
 11 10  1  0
  3  6  2  0
 15 16  2  0
M  END

Associated Targets(Human)

KCNJ11 Tclin Sulfonylurea receptors; K-ATP channels (596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 430.30Molecular Weight (Monoisotopic): 429.0046AlogP: 3.14#Rotatable Bonds: 3
Polar Surface Area: 72.47Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.41CX LogD: 1.41
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.16

References

1. Carroll WA, Altenbach RJ, Bai H, Brioni JD, Brune ME, Buckner SA, Cassidy C, Chen Y, Coghlan MJ, Daza AV, Drizin I, Fey TA, Fitzgerald M, Gopalakrishnan M, Gregg RJ, Henry RF, Holladay MW, King LL, Kort ME, Kym PR, Milicic I, Tang R, Turner SC, Whiteaker KL, Yi L, Zhang H, Sullivan JP..  (2004)  Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.,  47  (12): [PMID:15163196] [10.1021/jm030356w]

Source